Skip to main content
Premium Trial:

Request an Annual Quote

Daniel Caserza, Matthew Hogan, Gail Page, Stephen Scherer

Premium

Daniel Caserza, interim chief financial officer of Ciphergen Biosystems, is expected to resign this week, according to documents filed with the Securities and Exchange Commission. He became the interim CFO in March after Matthew Hogan abruptly resigned.

Gail Page, the company's president and chief executive officer, will act as interim chief financial officer until the company finds a permanent replacement.

Ciphergen has hired the Financial Leadership Group to help it prepare financial statements until a replacement is appointed.


Stephen Scherer has joined CombiMatrix Molecular Diagnostics' science advisory board.

Scherer is a senior scientist in genetics and genomic biology at The Hospital for Sick Children in Canada and associate professor of medicine at the University of Toronto. He is also director of the Centre for Applied Genomics and associate chief of research at the hospital.

CombiMatrix Molecular Diagnostics is wholly owned by CombiMatrix.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.